U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4689146891Clinical Safety for the Inspiratory Muscle TrainingCompletedNo Results AvailableHeart Diseases|Lung DiseaseOther: Inspiratory Muscle Traininghttps://ClinicalTrials.gov/show/NCT01952002
4689246892Intra-monocyte Imiglucerase Kinetics in Gaucher DiseaseRecruitingNo Results AvailableGaucher DiseaseDrug: Imiglucérase (drug) pharmacokineticshttps://ClinicalTrials.gov/show/NCT01951989
4689346893Yoga for Aromatase Inhibitor-associated Joint PainActive, not recruitingNo Results AvailableBreast CancerOther: Questionnaires|Other: Yoga Classeshttps://ClinicalTrials.gov/show/NCT01951976
4689446894Sub-dissociative Ketamine for the Management of Acute Pediatric PainRecruitingNo Results AvailablePainDrug: Ketamine|Drug: Morphinehttps://ClinicalTrials.gov/show/NCT01951963
4689546895Nicardipine vs Esmolol Craniotomy EmergenceCompletedHas ResultsBrain TumorsDrug: Nicardipine|Drug: Esmololhttps://ClinicalTrials.gov/show/NCT01951950
4689646896Herring and Mackerel Intervention and Learning AbilitiesActive, not recruitingNo Results AvailableCognitive EnhancementDietary Supplement: Fish Meals|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01951937
4689746897LIME Study (LFB IVIg MMN Efficacy Study)RecruitingNo Results AvailableMotor Neuron DiseaseDrug: Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL)|Drug: Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)https://ClinicalTrials.gov/show/NCT01951924
4689846898Effectiveness of Ketamine in Malignant Neuropathic Pain ReliefRecruitingNo Results AvailablePain, IntractableDrug: Ketamine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01951911
4689946899Effects of Montelukast on Airway Regulatory T Cells in AsthmaRecruitingNo Results AvailableAsthmaDrug: Montelukasthttps://ClinicalTrials.gov/show/NCT01951898
4690046900Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD PreventionRecruitingNo Results AvailableChronic Myelogenous Leukemia|Acute Lymphoblastic Leukemia|Acute Myeloid Leukemia|Acute Biphenotypic Leukemia|Myelodysplastic Syndrome|Myeloproliferative Neoplasm|Non-Hodgkin Lymphoma|Hodgkins Disease|Chronic Lymphocytic Leukemia|Multiple MyelomaDrug: tacrolimus|Drug: methotrexate|Drug: Mycophenolate mofetil|Drug: Methotrexate (low dose)https://ClinicalTrials.gov/show/NCT01951885
4690146901Treatment for Caffeine DependenceRecruitingNo Results AvailableCaffeine Use Disorder (DSM-5 Condition for Further Study)Behavioral: Manual-based treatment for caffeine dependencehttps://ClinicalTrials.gov/show/NCT01951872
4690246902Effects of a Homeopathic Anti-inflammatory Topical Cream on Ulcers and Neuropathy in the Diabetic FootRecruitingNo Results AvailableDiabetic NeuropathyOther: Neuropathy/Ulcer Homeopathic topical creamhttps://ClinicalTrials.gov/show/NCT01951859
4690346903To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid TumoursCompletedNo Results AvailableMalignant Solid TumourDrug: BIBF 1120https://ClinicalTrials.gov/show/NCT01951846
4690446904Long Term Significance (Survival) of LCI in Patients With Cystic FibrosisWithdrawnNo Results AvailableCystic Fibrosis (CF)Device: EasyOne Pro and Ecomedicshttps://ClinicalTrials.gov/show/NCT01951833
4690546905Comparison of Two Topical Anesthetics: Benzocaine Versus PliaglisRecruitingNo Results AvailableAnesthesia of Mucous MembraneDrug: Pliaglis|Drug: Benzocaine|Drug: Articainehttps://ClinicalTrials.gov/show/NCT01951820
4690646906Psychological Interventions for Gynecologic CancerRecruitingNo Results AvailableGynecologic CancerBehavioral: Psychotherapyhttps://ClinicalTrials.gov/show/NCT01951807
4690746907Validation of a Community Survey Methodology for Measuring PMTCT Program ImpactRecruitingNo Results AvailableHIVhttps://ClinicalTrials.gov/show/NCT01951794
4690846908Neutrophil CD64 for Early Diagnosis of Nosocomial Infection in Preterm NewbornsRecruitingNo Results AvailableNosocomial InfectionOther: blood samplehttps://ClinicalTrials.gov/show/NCT01951781
4690946909Efficacy and Safety of Garamycin® Sponge (Gentamicin-Collagen Sponge) in Diabetic Patients With a Moderate or Severe Foot Ulcer InfectionRecruitingNo Results AvailableDiabetic Foot UlcerDrug: Garamycin Sponge (Gentamicin-Collagen sponge)|Drug: Systemic Antibiotichttps://ClinicalTrials.gov/show/NCT01951768
4691046910Phase IV Study of Tarceva in Patients With Advanced Stage IIIB/ IV Non-small Cell Lung Cancer (NSCLC)CompletedNo Results AvailableNon-small Cell Lung Cancerhttps://ClinicalTrials.gov/show/NCT01951755
4691146911Dose Finding Study In Subjects With Crow's FeetCompletedNo Results AvailableLateral Canthal Lines|Crow's FeetBiological: ANT-1401|Biological: Vehiclehttps://ClinicalTrials.gov/show/NCT01951742
4691246912The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin SecretionActive, not recruitingNo Results AvailablePre-diabetesDrug: Control|Drug: Xenin-25 without atropine|Drug: GIP without atropine|Drug: Placebo with atropine|Drug: Xenin-25 with atropine|Drug: GIP with atropine|Drug: GIP plus Xenin-25 without atropine|Drug: GIP plus Xenin-25 with atropinehttps://ClinicalTrials.gov/show/NCT01951729
4691346913Effects of Xenin-25 on Insulin Secretion and Gastric Emptying in Humans With and Without a Complete Truncal VagotomyActive, not recruitingNo Results AvailableDoes the Vagus Nerve Mediate the Effects of Xenin-25Drug: Graded Glucose Infusion with Placebo|Drug: Graded Glucose Infusion with GIP Alone|Drug: Graded Glucose Infusion with xenin-25 alone|Drug: Graded Glucose Infusion with GIP plus xenin-25|Drug: Meal Tolerance Test with Placebo|Drug: Meal Tolerance Test with xenin-25https://ClinicalTrials.gov/show/NCT01951716
4691446914Senofilcon A Investigational Manufacturing ProcessCompletedHas ResultsVisual Acuity|Comfort|Overall VisionDevice: senofilcon A|Device: senofilcon Ahttps://ClinicalTrials.gov/show/NCT01951703
4691546915Phase II Study of VS-6063 in Patients With KRAS Mutant Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableNon Small Cell Lung Cancer|Lung CancerDrug: defactinib (VS-6063)https://ClinicalTrials.gov/show/NCT01951690
4691646916Safety and Efficacy Study of Adjuvanted Prophylactic Hepatitis B VaccineRecruitingNo Results AvailableExposure to Hepatitis B VirusDrug: HBsAg|Biological: PreS HBsAg|Biological: Advax-1(TM)|Biological: Advax-2(TM)|Biological: Advax-3(TM)|Biological: Alumhttps://ClinicalTrials.gov/show/NCT01951677
4691746917Feasibility and Preliminary Efficacy of Hatha Yoga in Head and Neck Cancer SurvivorsRecruitingNo Results AvailableHead Neck CancerOther: Baseline Study Measures|Behavioral: Yoga Evaluation|Behavioral: Yoga Program|Behavioral: Yoga Practice Plan|Other: Study Assessmentshttps://ClinicalTrials.gov/show/NCT01951664
4691846918Effect of Exenatide on Liver and Heart Fat and InflammationCompletedNo Results AvailableType 2 Diabetes MellitusDrug: Exenatide|Drug: Glipizidehttps://ClinicalTrials.gov/show/NCT01951651
4691946919Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)Active, not recruitingNo Results AvailableHeart FailureDrug: Vericiguat (BAY1021189) (1.25 mg)|Drug: Vericiguat (BAY1021189) (5 mg)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01951638
4692046920Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure With Reduced Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-REDUCED)CompletedNo Results AvailableHeart FailureDrug: Vericiguat (BAY1021189) (1.25 mg)|Drug: Vericiguat (BAY1021189) (5 mg)|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01951625

* Görseller ve İçerik tekif hakkına sahip olabilir